|Articles|February 15, 2003

BioPharm International

  • BioPharm International-02-01-2003
  • Volume 16
  • Issue 2

Outsourcing Outlook: Contract Services' Crystal Ball

Author(s)Jim Miller

by Jim Miller, Bio/Pharmaceutical Outsourcing Report Developments in 2002 such as acquisitions, excess manufacturing capacity, and less funding for biotechnology will continue to affect the industry long into the new year.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

almost 23 years ago

Becoming a Partner of Choice and Evaluating Prospective Alliances

almost 23 years ago

Using Amino Acid Analysis to Determine Absorptivity Constants: A Validation Case Study Using Bovine Serum Albumin

almost 23 years ago

Guest Editorial: Maybe You Need a Corporate Marriage Counselor

almost 23 years ago

Inside Washington: AIDS Prevention Campaign Spotlights Biotech

almost 23 years ago

The Double Helix at 50: A Half Century of Innovation in the Words of Eight Distinguished Scientists

almost 23 years ago

Survival Strategies: Keeping Tabs on Training

almost 23 years ago

Biotech World: Contract Manufacturing: Diversity in the European Marketplace

almost 2023 years ago

Virus Inactivation in the 1990s ? and into the 21st Century: Part 5: Disinfection

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!